Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Refining the origins of breast cancer

Cyclin D1 may be overexpressed in most breast cancers. Is this a critical early step in breast carcinogenesis (pages 1257–1260)?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Rosai, J. Borderline epithelial lesions of the breast. Am. J. Surg. Path. 15, 209–221 (1991).

    Article  CAS  PubMed  Google Scholar 

  2. Rosen, P.P. Proliferative breast “ disease,” an unresolved diagnostic dilemma. Cancer 71, 3798–3807 (1993).

    Article  CAS  PubMed  Google Scholar 

  3. Bose, S., Lesser, M.L., Norton, L. & Rosen, P.P. Immunophenotype of intraductal carcinoma. Arch. Pathol. Lab. Med. 120, (in the press).

  4. Chen, Y. et al. Aberrant subcellular localization of BRCA1 in breast cancer. Science 270, 789–791 (1995).

    Article  CAS  PubMed  Google Scholar 

  5. Weinstat-Saslow, D. et al. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature Med. 1, 1257–1260 (1995).

    Article  CAS  PubMed  Google Scholar 

  6. Motokura, T. & Arnold, A. PRAD1/cyclin Dl proto-oncogene: Genomic organization, 5′DNA sequence, and sequence of a tumor-specific rearrangement breakpoint. Genes Chrom. Cancer 7, 89–95 (1993).

    Article  CAS  PubMed  Google Scholar 

  7. Buckley, M.F. et al. Expression and amplification of cyclin genes in human breast cancer. Oncogene 8, 2127–2133 (1993).

    CAS  PubMed  Google Scholar 

  8. Sherr, C.J. Cycling on Cue. Cell 79, 551–555 (1994).

    Article  CAS  PubMed  Google Scholar 

  9. Lukas, J., Aagaard, L., Strauss, M. & Bartek, J. Oncogenic aberrations of p16INK4/CDKN2 and cyclin Dl cooperate to deregulate G1, control. Cancer Res. 55, 4818–4823 (1995).

    CAS  PubMed  Google Scholar 

  10. Wang, T.C. et al. Mammary hyperplasia and carcinoma in MMTV-cyclin Dl transgenic mice. Nature 369, 669–671 (1994).

    Article  CAS  PubMed  Google Scholar 

  11. Sicinski, P. et al. Cyclin Dl provides a link between development and oncogenesis in the retina and breast. Cell 82, 621–630 (1995).

    Article  CAS  PubMed  Google Scholar 

  12. Rosenwald, I.E., Lzaris-Karatzas, A., Sonenberg, N. & Schmidt, E.V. Elevated levels of cyclin Dl protein in response to increased expression of eukaryotic initiation factor 4E. Molec. cell. Biol. 13, 7358–7363 (1993).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Musgrove, E.A. et al. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Molec. cell. Biol. 13, 3577–3587 (1993).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Gilewski, T. & Norton, L. Cytokinetics of breast cancer.inDiseases of the Breast (eds Harris, J.R., Lippmanm, M.E., Morrow, M. & Hellman, S.) (J.B. Lippincott, New York, in the press).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Norton, L., Rosen, P. & Rosen, N. Refining the origins of breast cancer. Nat Med 1, 1250–1251 (1995). https://doi.org/10.1038/nm1295-1250

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1295-1250

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing